Advertisement

Health Catalyst, Inc. HCAT

Set alert

Price alert · HCAT

All alert types
1.69 USD -0.10 -5.59%

At close · Oct 30

1.69 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
1.68 × 2
Ask
1.70 × 2
1.66 Day range 1.84
0.996 52-week range 3.28
YTD
-29.29%
1 year
-48.48%
Open
1.79
Prev close
1.79
Mkt cap
127.18M
Vol
344.99K
Avg vol
590.89K
EPS
-3.69
P/E
0.00
Div yield
0.00%
More statistics
Low
1.66
High
1.84
Forward P/E
16.52
Beta
1.32
Short ratio
5.03
Inst. own
90.64%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
8.10
200-d avg
7.27
1y target
11.41

2Y chart

Chart tools
Interval

Events in this range
  • Nov 6, 2024Earnings: 0.07; estimate 0.1; surprise -30%
  • Nov 7, 2024Rating: RBC Capital · Sector Perform → Sector Perform
  • Nov 13, 2024Rating: Citigroup · Buy → Buy
  • Nov 14, 2024Rating: Stephens & Co. · Equal-Weight → Equal-Weight
  • Nov 26, 2024Rating: Piper Sandler · Overweight → Overweight
Signals (94)
NameDateAgo
SMA: BearishOct 30, 20261 day ago
SMA: BearishOct 30, 20261 day ago
MACD: Buy SignalOct 29, 20262 days ago
SMA: BullishOct 28, 20263 days ago
SMA: BullishOct 28, 20263 days ago
SMA: BearishOct 23, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BearishOct 19, 20261 week ago
MACD: Sell SignalOct 19, 20261 week ago
SMA: BearishOct 16, 20262 weeks ago
SMA: BullishOct 15, 20262 weeks ago
SMA: BullishOct 15, 20262 weeks ago
SMA: BearishSep 23, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BullishSep 22, 20261 month ago
MACD: Buy SignalSep 1, 20262 months ago
SMA: BearishAug 7, 20262 months ago
SMA: BearishAug 7, 20262 months ago
MACD: Sell SignalAug 7, 20262 months ago
MACD: Buy SignalAug 5, 20262 months ago
SMA: BullishJul 24, 20263 months ago
SMA: BearishJul 23, 20263 months ago
MACD: Sell SignalJul 17, 20263 months ago
RSI: OverboughtJul 9, 20263 months ago
RSI: OverboughtJul 2, 20264 months ago
MACD: Buy SignalJun 26, 20264 months ago
MACD: Sell SignalJun 24, 20264 months ago
RSI: OverboughtJun 4, 20264 months ago
MACD: Buy SignalMay 29, 20265 months ago
SMA: BullishMay 20, 20265 months ago
MACD: Sell SignalMay 14, 20265 months ago
SMA: BearishMay 13, 20265 months ago
SMA: BullishMay 1, 20266 months ago
RSI: OversoldApr 8, 20266 months ago
MACD: Buy SignalMar 31, 20267 months ago
MACD: Sell SignalMar 13, 20267 months ago
RSI: OversoldMar 13, 20267 months ago
MACD: Buy SignalMar 4, 20268 months ago
RSI: OversoldFeb 12, 20268 months ago
MACD: Sell SignalJan 23, 20269 months ago
MACD: Buy SignalJan 22, 20269 months ago
MACD: Sell SignalJan 20, 20269 months ago
MACD: Buy SignalJan 6, 20269 months ago
MACD: Sell SignalJan 2, 202610 months ago
MACD: Buy SignalDec 29, 202510 months ago
MACD: Sell SignalDec 15, 202510 months ago
SMA: BearishDec 2, 202511 months ago
SMA: BullishNov 26, 202511 months ago
MACD: Buy SignalNov 25, 202511 months ago
RSI: OversoldNov 12, 202511 months ago
SMA: BearishNov 4, 202512 months ago
MACD: Sell SignalNov 4, 202512 months ago
SMA: BullishOct 16, 20251 year ago
MACD: Buy SignalOct 14, 20251 year ago
MACD: Sell SignalOct 13, 20251 year ago
MACD: Buy SignalOct 3, 20251 year ago
MACD: Sell SignalSep 12, 20251 year ago
SMA: BearishAug 29, 20251 year ago
SMA: BullishAug 27, 20251 year ago
MACD: Buy SignalAug 22, 20251 year ago
RSI: OversoldAug 8, 20251 year ago
SMA: BearishJul 30, 20251 year ago
MACD: Sell SignalJul 30, 20251 year ago
SMA: BearishJul 24, 20251 year ago
MACD: Buy SignalJul 23, 20251 year ago
SMA: BullishJul 22, 20251 year ago
MACD: Sell SignalJul 15, 20251 year ago
SMA: BearishJul 11, 20251 year ago
SMA: BullishJul 1, 20251 year ago
MACD: Buy SignalJul 1, 20251 year ago
MACD: Sell SignalJun 17, 20251 year ago
SMA: BearishJun 13, 20251 year ago
SMA: BullishJun 12, 20251 year ago
SMA: BearishJun 11, 20251 year ago
SMA: BullishJun 6, 20251 year ago
SMA: BearishJun 4, 20251 year ago
SMA: BullishJun 3, 20251 year ago
MACD: Buy SignalJun 3, 20251 year ago
MACD: Sell SignalMay 20, 20251 year ago
SMA: BearishMay 15, 20251 year ago
SMA: BullishMay 12, 20251 year ago
MACD: Buy SignalApr 23, 20251 year ago
MACD: Sell SignalApr 7, 20251 year ago
MACD: Buy SignalMar 17, 20251 year ago
RSI: OversoldMar 7, 20251 year ago
RSI: OversoldFeb 27, 20251 year ago
MACD: Sell SignalFeb 25, 20251 year ago
MACD: Buy SignalJan 31, 20251 year ago
RSI: OversoldJan 22, 20251 year ago
RSI: OversoldJan 14, 20251 year ago
MACD: Sell SignalJan 13, 20251 year ago
MACD: Buy SignalJan 6, 20251 year ago

Key statistics

Market cap
422.28M
Enterprise value
408.49M
Trailing P/E
0.00
Forward P/E
16.52
PEG ratio
0.00
Price / sales
1.40
Price / book
1.19
EPS (TTM)
-1.34
Beta
1.32
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-26.20%
Revenue (TTM)
302.06M
Revenue growth
3.50%
Free cash flow
24.03M
Total cash
387.26M
Total debt
364.33M
Return on equity
-21.46%
Shares outstanding
60.85M
Short % of float
4.28%
50-day average
8.10
200-day average
7.27

Analyst view

Consensus: none

Price target (mean) 11.41 +575.1% upside
Target (low)
9.00
Target (mean)
11.41
Target (high)
16.00
Ratings (0m) 14 9 buy · 5 hold · 0 sell
  • Strong buy2
  • Buy7
  • Hold5
  • Sell0
  • Strong sell0

Next earnings

Aug 7, 2024

Expected Aug 7, 2024. Consensus EPS estimate 0.07649.

Earnings history

Financials — quick view

All financials
HCAT Revenue — quarterly 70.49M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
HCAT Net income — quarterly -40.54M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
HCAT EPS — quarterly -0.55
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

HCAT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 6, 2024Sep 1, 20240.100.07-0.03-30.00%
Aug 7, 2024Jun 1, 20240.090.12+0.03+33.33%
Aug 7, 2024Jun 1, 20240.09———
May 9, 2024Mar 1, 20240.030.05+0.02+66.67%
May 9, 2024Mar 1, 20240.03———
Feb 22, 2024Dec 1, 2023-0.010.02+0.03+300.00%

Upgrades / downgrades

HCAT analyst upgrades and downgrades
DateFirmActionFromTo
Nov 26, 2024Piper SandlerreitOverweightOverweight
Nov 14, 2024Stephens & Co.mainEqual-WeightEqual-Weight
Nov 13, 2024CitigroupmainBuyBuy
Nov 7, 2024RBC CapitalmainSector PerformSector Perform
Oct 8, 2024Evercore ISI GroupmainOutperformOutperform
Oct 4, 2024Cantor FitzgeraldreitOverweightOverweight

About Health Catalyst, Inc.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Sector
Healthcare
Industry
Health Information Services
Country
United States

News

Your note

Sign in to keep a note on HCAT — it syncs with the Stock Master app.

Insider holders

HCAT insider holders
InsiderRelationLatest transactionDateShares held
ALGER JASONChief Financial OfficerSaleDec 5, 202486,712
FREEMAN KEVIN LEEOfficerSaleDec 1, 2024236,950
GALLAGHER DUNCAN PDirectorStock Award(Grant)Nov 28, 202478,938
HOGGARD GREEN JILLDirectorStock Award(Grant)Nov 28, 202427,706
KANE JOHN ADirectorStock Award(Grant)Jun 12, 2024130,995
LANDRY BENJAMINGeneral CounselSaleDec 5, 202472,250

Institution ownership

HCAT institution ownership
Holder% heldSharesValueReported
Blackrock Inc.9.10%5,538,10938.43MSep 29, 2024
Vanguard Group Inc7.53%4,580,56331.79MSep 29, 2024
First Light Asset Management, LLC7.06%4,296,49029.82MSep 29, 2024
Impax Asset Management Group Plc4.20%2,554,47517.73MSep 29, 2024
Daventry Group, LP3.97%2,417,60216.78MSep 29, 2024
Primecap Management Company3.95%2,404,46216.69MSep 29, 2024

Fund ownership

HCAT fund ownership
Holder% heldSharesValueReported
Pax World Small Cap Fund4.20%2,554,47517.73MSep 29, 2024
Primecap Odyssey Aggressive Growth Fund3.49%2,124,40614.74MSep 29, 2024
Vanguard Total Stock Market Index Fund2.99%1,822,12812.65MSep 29, 2024
iShares Russell 2000 ETF2.47%1,505,11210.45MOct 30, 2024
Vanguard Extended Market Index Fund1.56%949,7506.59MSep 29, 2024
American Beacon Small Cap Value Fd1.04%633,4594.40MOct 30, 2024
Advertisement